Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
Linear Formula:
(O2N)2C6H3CONH2
CAS Number:
Molecular Weight:
211.13
EC Number:
204-499-8
UNSPSC Code:
41116107
PubChem Substance ID:
Beilstein/REAXYS Number:
7096825
MDL number:
InChI key
UUKWKUSGGZNXGA-UHFFFAOYSA-N
InChI
1S/C7H5N3O5/c8-7(11)4-1-5(9(12)13)3-6(2-4)10(14)15/h1-3H,(H2,8,11)
SMILES string
NC(=O)c1cc(cc(c1)[N+]([O-])=O)[N+]([O-])=O
grade
analytical standard
product line
VETRANAL®
shelf life
limited shelf life, expiry date on the label
technique(s)
HPLC: suitable, gas chromatography (GC): suitable
mp
183-185 °C (lit.)
application(s)
clinical
forensics and toxicology
pharmaceutical (small molecule)
format
neat
Application
Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.
Legal Information
VETRANAL is a registered trademark of Merck KGaA, Darmstadt, Germany
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral
Storage Class
11 - Combustible Solids
wgk
WGK 3
ppe
dust mask type N95 (US), Eyeshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
N W Shappell et al.
Chemosphere, 38(8), 1757-1762 (1999-04-02)
Colostomized chickens given oral doses of 3,5-dinitrobenzamide (nitromide) cleared nitromide predominantly through the urine (58% of dose) and feces (21% of dose). Rats cleared 52% of nitromide via urinary excretion and 44% via feces. Major urinary metabolites for both chickens
V Facchini et al.
Xenobiotica; the fate of foreign compounds in biological systems, 10(4), 299-305 (1980-04-01)
1. Nitromide (3,5-dinitrobenzamide) is reduced to monoamino- and diamino-metabolites in vitro on anaerobic incubation with rat intestinal microflora. This conversion is suppressed by the antibiotics neomycin, tetracycline and bacitracin. 2. Nitromide is also in part reduced to monoamino but not
V Facchini et al.
Xenobiotica; the fate of foreign compounds in biological systems, 10(4), 289-297 (1980-04-01)
1. Following oral administration of nitromide (3,5-dinitrobenzamide) to rats, 67.9% of the dose was excreted in urine and 32.6% in the faeces in 96 h. Significant biliary excretion of nitromide metabolites also occurred, although no evidence of enterohepatic cycling was
A A Ensafi et al.
Colloids and surfaces. B, Biointerfaces, 87(2), 480-488 (2011-07-06)
A new catechol-derivative compound, N-(3,4-dihydroxyphenethyl)-3,5-dinitrobenzamide, was synthesized and used to construct a modified-carbon nanotubes paste electrode. The electro-oxidation of captopril at the surface of the modified electrode was studied using cyclic voltammetry, chronoamperometry, and electrochemical impedance spectroscopy. Under the optimized
Núria Rubio et al.
Journal of chromatography. A, 1217(8), 1183-1190 (2009-12-22)
The racemic compound (+/-)-N-(3,4-cis-3-decyl-1,2,3,4-tetrahydrophenanthren-4-yl)-3,5-dinitrobenzamide ((+/-)-1), an analogue of increased lipophilicity of the chiral selector (CS) contained in the Whelk-O HPLC chiral stationary phase (CSP) has been resolved into its enantiomers by applying centrifugal partition chromatography (CPC). Considering the known enantioselectivity
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service